| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 74470* | 2016 |
| Biological, clinical and population relevance of 95 loci for blood lipids TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ... Nature 466 (7307), 707-713, 2010 | 4159 | 2010 |
| Discovery and refinement of loci associated with lipid levels Nature genetics 45 (11), 1274-1283, 2013 | 3104 | 2013 |
| Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study BF Voight, GM Peloso, M Orho-Melander, R Frikke-Schmidt, M Barbalic, ... The Lancet 380 (9841), 572-580, 2012 | 2663 | 2012 |
| Mixed linear model approach adapted for genome-wide association studies Z Zhang, E Ersoz, CQ Lai, RJ Todhunter, HK Tiwari, MA Gore, ... Nature genetics 42 (4), 355-360, 2010 | 2219 | 2010 |
| Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans S Kathiresan, O Melander, C Guiducci, A Surti, NP Burtt, MJ Rieder, ... Nature genetics 40 (2), 189-197, 2008 | 1649 | 2008 |
| Common variants at 30 loci contribute to polygenic dyslipidemia S Kathiresan, CJ Willer, GM Peloso, S Demissie, K Musunuru, EE Schadt, ... Nature genetics 41 (1), 56-65, 2009 | 1597 | 2009 |
| Common variants associated with plasma triglycerides and risk for coronary artery disease R Do, CJ Willer, EM Schmidt, S Sengupta, C Gao, GM Peloso, ... Nature genetics 45 (11), 1345-1352, 2013 | 1060 | 2013 |
| Familial lipoprotein disorders in patients with premature coronary artery disease. JJ Genest Jr, SS Martin-Munley, JR McNamara, JM Ordovas, J Jenner, ... Circulation 85 (6), 2025-2033, 1992 | 935 | 1992 |
| Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease TG and HDL Working Group of the Exome Sequencing Project, National Heart ... New England Journal of Medicine 371 (1), 22-31, 2014 | 867 | 2014 |
| Timing of food intake predicts weight loss effectiveness M Garaulet, P Gómez-Abellán, JJ Alburquerque-Béjar, YC Lee, ... International journal of obesity 37 (4), 604-611, 2013 | 841 | 2013 |
| Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals F Asnicar, S Berry, A Valdes Nature Medicine 27 (2), 321-332, 2021 | 773 | 2021 |
| Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study CJ O’Donnell, K Lindpaintner, MG Larson, VS Rao, JM Ordovas, ... Circulation 97 (18), 1766-1772, 1998 | 760 | 1998 |
| The PhenX Toolkit: get the most from your measures CM Hamilton, LC Strader, JG Pratt, D Maiese, T Hendershot, RK Kwok, ... American journal of epidemiology 174 (3), 253-260, 2011 | 758 | 2011 |
| Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008 J López-Miranda, F Pérez-Jiménez, E Ros, R De Caterina, L Badimón, ... Nutrition, metabolism and cardiovascular diseases 20 (4), 284-294, 2010 | 758 | 2010 |
| Apolipoprotein E alleles and risk of coronary disease: a meta-analysis PWF Wilson, EJ Schaefer, MG Larson, JM Ordovas Arteriosclerosis, thrombosis, and vascular biology 16 (10), 1250-1255, 1996 | 729 | 1996 |
| Low density lipoprotein particle size and coronary artery disease. H Campos, JJ Genest Jr, E Blijlevens, JR McNamara, JL Jenner, ... Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 12 (2), 187-195, 1992 | 673 | 1992 |
| Human postprandial responses to food and potential for precision nutrition SE Berry, AM Valdes, DA Drew, F Asnicar, M Mazidi, J Wolf, J Capdevila, ... Nature medicine 26 (6), 964-973, 2020 | 670 | 2020 |
| Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada J Marrugat, P Solanas, R D’Agostino, L Sullivan, J Ordovas, F Cordón, ... Revista española de cardiología 56 (3), 253-261, 2003 | 652 | 2003 |
| Lipoprotein (a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial EJ Schaefer, S Lamon-Fava, JL Jenner, JR McNamara, JM Ordovas, ... Jama 271 (13), 999-1003, 1994 | 652 | 1994 |
Daniel LevyNational Heart, Lung, and Blood InstituteBestätigte E-Mail-Adresse bei nih.gov